Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchIndependent Academic Research Groups
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

Unity Health Toronto

Canada
5 Trials

Toronto-based health system anchored by St. Michael's Hospital and St. Joseph's Health Centre. The Pinnacle Research Group at St. Michael's is running first-of-its-kind MDMA, ketamine, and psilocybin trials for chronic neuropathic pain, establishing Unity Health Toronto as a leading Canadian centre for psychedelic research.

Academic Research

0 papers

Published Papers

0

Trial Involvement

5

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
Canada
Website
Visit

Sponsored Trials

5
RecruitingII

Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial

Start Date
Compounds
MDMA, Placebo
RecruitingII

Psilocybin for Enhanced Analgesia in Chronic Neuropathic Pain (PEACE-PAIN)

Start Date
Compounds
Psilocybin, Placebo
Not yet recruitingII

Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD

Start Date
Compounds
Psilocybin
CompletedIV

Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: A Randomized Controlled Pilot Trial

Start Date
Compounds
Ketamine, Placebo
Unknown statusNA

Auditory MMN EEG in TRD in Response to Ketamine

Start Date
Compounds
Ketamine